Circulating Tumour DNA Analysis of EGFR-Mutant Non-Small Cell Lung Cancer Patients Receiving Osimertinib Following Previous Tyrosine Kinase Inhibitor Treatment

J. Beagan, S. Bach, R. A. A. van Boerdonk, E. van Dijk, E. Thunnissen, D. van den Broek, J. Weiss, G. Kazemier, D. M. Pegtel, I. Bahce, B. Ylstra, D. A. M. Heideman

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S56-S56
JournalJournal of molecular diagnostics
Volume22
Issue number5
Publication statusPublished - May 2020

Cite this